论文部分内容阅读
Objective Serum biomarkers of diabetic neuropathy are being actively sought to facilitate the diagnosis,measure the progression,and assess the benefits of therapeutic intervention in patients with diabetic neuropathy.Methods MALDI-TOF-MS has been broadly used to screen biomarkers for variety of diseases,the identification and validation of the revealed biomarkers focused more attention.